Display Settings:

Format

Send to:

Choose Destination
    Proc Natl Acad Sci U S A. 2007 May 29;104(22):9387-92. Epub 2007 May 17.

    Multigene amplification and massively parallel sequencing for cancer mutation discovery.

    Source

    Stanford Genome Technology Center, Stanford University, Palo Alto, CA 94304, USA. fdahl@stanford.edu

    Abstract

    We have developed a procedure for massively parallel resequencing of multiple human genes by combining a highly multiplexed and target-specific amplification process with a high-throughput parallel sequencing technology. The amplification process is based on oligonucleotide constructs, called selectors, that guide the circularization of specific DNA target regions. Subsequently, the circularized target sequences are amplified in multiplex and analyzed by using a highly parallel sequencing-by-synthesis technology. As a proof-of-concept study, we demonstrate parallel resequencing of 10 cancer genes covering 177 exons with average sequence coverage per sample of 93%. Seven cancer cell lines and one normal genomic DNA sample were studied with multiple mutations and polymorphisms identified among the 10 genes. Mutations and polymorphisms in the TP53 gene were confirmed by traditional sequencing.

    PMID:
    17517648
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC1871563
    Free PMC Article

    Images from this publication.See all images (2) Free text

    Fig. 2.
    Fig. 1.

      Supplemental Content

      Icon for HighWire Press Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk